Clarifying Bacne Spray
NDC Package 68479-782-02
Package Information
Clarifying Bacne (salicylic acid) sprays is clean the skin thoroughly before applying this product.Cover the entire affected area with a thin layer one to three times daily.Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.If bothersome dryness or peeling occurs, reduce application to once a day or every other day.Hold the spray about a foot and a half away from your body and mist onto clean, dry skin.Let it sink into skin for 30-60 seconds. This formulation utilizes a spray delivery system. Marketed by Dermalogica, Llc., this product is identified by NDC 68479-782 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 2560235 - salicylic acid 1 % Topical Spray
- RxCUI: 2560235 - salicylic acid 10 MG/ML Topical Spray
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68479 - Dermalogica, Llc.
- 68479-782 - Clarifying Bacne
- 68479-782-02 - 177 mL in 1 BOTTLE, SPRAY
- 68479-782 - Clarifying Bacne
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68479-782-02 identifies a specific commercial package of 177 ml in 1 bottle, spray of Clarifying Bacne, a human over the counter drug labeled by Dermalogica, Llc.. This spray is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dermalogica, Llc. on October 01, 2023. The current certification is valid through December 31, 2026.
How is this Dermalogica, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68479078202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.